Mortality Risk Over Time in Patients with Carbapenem-Resistant Gram-Negative Bloodstream Infections: Implications for Recruitment and Timing of Primary Endpoints in Clinical Trials

International Journal of Antimicrobial Agents · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles